Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in RCUS — Arcus Biosciences, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to RCUS Full portfolio

Position in RCUS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,096,813
-$5,049,829 QoQ
Shares Held
143,371
-58.1% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RCUS Over Time

Shares Held

Position Value (USD)

Derivatives in RCUS

reported options exposure · as of Mar 31, 2026
CallValue
$1,254,960
CallShares
58,100
PutValue
$324,000
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. RCUS ranks #79 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CYTK
Cytokinetics Inc
 898,951 $59,249,860
2 ALNY
Alnylam Pharmaceuticals, Inc.
 174,268 $57,660,053
3 AGIO
Agios Pharmaceuticals, Inc.
 1,344,953 $45,499,759
4 ABVX
Abivax S.A.
 381,282 $42,455,750
5 BBIO
BridgeBio Pharma, Inc.
 398,943 $29,625,507
6 INSM
INSMED Inc
 173,630 $28,391,977
7 CRSP
CRISPR Therapeutics AG
 593,406 $28,228,323
8 TERN
Terns Pharmaceuticals, Inc.
 521,571 $27,497,223

All Filings in RCUS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,096,813 143,371
2026-03-31 $1,254,960 58,100
2026-03-31 $324,000 15,000
2025-12-31 $8,146,642 341,865
2025-12-31 $650,559 27,300
2025-09-30 $814,640 59,900
2025-09-30 $5,292,317 389,141
2025-09-30 $247,520 18,200
2025-06-30 $630,850 77,500
2025-06-30 $2,836,464 348,460
2025-03-31 $178,195 22,700
2025-03-31 $164,850 21,000
2025-03-31 $851,246 108,439
2024-12-31 $552,419 37,100
2024-12-31 $1,105,642 74,254
2024-12-31 $1,268,628 85,200
2024-09-30 $1,121,093 73,322
2024-09-30 $1,311,882 85,800
2024-09-30 $669,702 43,800
2024-06-30 $2,298,420 150,914
2024-06-30 $689,919 45,300
2024-06-30 $944,260 62,000
2024-03-31 $1,888,000 100,000
2024-03-31 $1,538,720 81,500
2024-03-31 $5,948,162 315,051
2023-12-31 $1,358,010 71,100
2023-12-31 $2,230,440 116,777
2023-12-31 $1,967,300 103,000
2023-09-30 $5,736,820 319,600
2023-09-30 $1,751,920 97,600
2023-09-30 $5,450,372 303,642
2023-06-30 $6,450,456 317,600
2023-06-30 $2,587,494 127,400
2023-06-30 $7,666,455 377,472
2023-03-31 $3,352,512 183,800
2023-03-31 $4,781,068 262,120
2023-03-31 $1,333,344 73,100
2022-12-31 $2,690,468 130,100
2022-12-31 $3,714,128 179,600
2022-12-31 $1,695,966 82,010
2022-09-30 $2,231,448 85,300
2022-09-30 $2,720,665 104,001
2022-09-30 $3,233,376 123,600
2022-06-30 $3,773,126 148,900
2022-06-30 $3,740,184 147,600
2022-06-30 $2,169,788 85,627
2022-03-31 $1,044,636 33,100
2022-03-31 $3,206,496 101,600
2022-03-31 $4,249,585 134,651
2021-12-31 $2,287,647 56,527

Report a Problem

Category
Description
Email (optional, for follow-up)